Foresite Capital Management Vi LLC Rapt Therapeutics, Inc. Transaction History
Foresite Capital Management Vi LLC
- $183 Billion
- Q1 2025
A detailed history of Foresite Capital Management Vi LLC transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Foresite Capital Management Vi LLC holds 12,500,000 shares of RAPT stock, worth $10.1 Million. This represents 8.35% of its overall portfolio holdings.
Number of Shares
12,500,000
Previous 12,500,000
-0.0%
Holding current value
$10.1 Million
Previous $19.8 Billion
22.78%
% of portfolio
8.35%
Previous 8.8%
Shares
1 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
134MCall Options Held
41.3KPut Options Held
100-
Medicxi Ventures Management (Jersey) LTD22.4MShares$18.1 Million7.04% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$10.6 Million0.5% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$10.6 Million3.85% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$9.53 Million0.24% of portfolio
-
Bvf Inc San Francisco, CA9.24MShares$7.48 Million0.5% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $24M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...